Ignite Creation Date:
2025-12-25 @ 4:25 AM
Ignite Modification Date:
2026-03-10 @ 8:06 PM
Study NCT ID:
NCT05322720
Status:
UNKNOWN
Last Update Posted:
2022-04-12
First Post:
2022-03-10
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
HR Positive, HER2 Negative Advanced Breast Cancer With Progression After Endocrine Therapy
Sponsor:
Taizhou EOC Pharma Co., Ltd.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-04
Start Date Type:
ESTIMATED
Primary Completion Date:
2023-03
Primary Completion Date Type:
ESTIMATED
Completion Date:
2025-05
Completion Date Type:
ESTIMATED
First Submit Date:
2022-03-10
First Submit QC Date:
None
Study First Post Date:
2022-04-12
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-04-07
Last Update Post Date:
2022-04-12
Last Update Post Date Type:
ACTUAL